The Risk of Autoimmunity Development following mRNA COVID-19 Vaccination

The broad spectrum of interactions between autoimmune diseases and the SARS-CoV-2 vaccination is not fully understood. This study aims to evaluate the prevalence of anti-nuclear antibodies (ANA), anti-ENA, anticardiolipin antibodies (ACL), and anti-beta-2 glycoprotein I antibodies (anti-β2GPI) befor...

Descripción completa

Detalles Bibliográficos
Autores principales: Świerkot, Jerzy, Madej, Marta, Szmyrka, Magdalena, Korman, Lucyna, Sokolik, Renata, Andrasiak, Iga, Morgiel, Ewa, Sebastian, Agata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788148/
https://www.ncbi.nlm.nih.gov/pubmed/36560659
http://dx.doi.org/10.3390/v14122655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788148/
https://www.ncbi.nlm.nih.gov/pubmed/36560659
http://dx.doi.org/10.3390/v14122655

Ejemplares similares